ENTITY
Hansoh Pharmaceutical Group

Hansoh Pharmaceutical Group (3692 HK)

172
Analysis
Health CareChina
Hansoh Pharmaceutical Group Company Limited operates as a pharmaceutical company. The Company manufactures and sells anti-infectives, anti-neoplastic agents, diabetes drugs, and other products. Hansoh Pharmaceutical Group markets its products throughout China.
more
Refresh
bullishESR Group
01 Jun 2019 11:47

ECM Weekly (1 Jun 2019) - Hansoh, China East Edu, GSX, CSSC (HK) Shipping, China Tobacco

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
30 May 2019 16:38

Hansoh Pharma (翰森制药) IPO: Strong Cornerstone Line-Up, Upside at Low End

Hansoh Pharma, the largest pharmaceutical listing in Hong Kong this year, launched its book building today. In our previous insights (links...

Logo
847 Views
Share
29 May 2019 14:01

Hansoh Pharma (翰森制药) IPO: Inebilizumab License-In from Viela Bio a Symbolic Deal

Just ahead of the launch of Hansoh Pharma's book building for its USD 1bn IPO, news reported today that Hansoh inked a license-in agreement with...

Logo
775 Views
Share
25 May 2019 01:51

ECM Weekly (25 May 2019) - ESR Cayman, Hansoh Pharma, Tai Hing, China East Edu, Haitong UniTrust

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
23 May 2019 09:44

Hansoh Pharma (翰森制药) IPO: Thoughts on Valuation

Hansoh Pharma has started pre-marketing its IPO to raise USD 1bn in its IPO. In our previous insights, we covered the company's major products and...

Logo
705 Views
Share
x